Jenny Viklund

1.0k citations

15 papers · 724 indexed · h-index 12

Impact in

Physiology top 10%
- Alzheimer's disease research and treatments
Molecular Biology
- Melanoma and MAPK Pathways
- Epigenetics and DNA Methylation

Papers in

Computational Theory and Mathematics 5
- Computational Drug Discovery Methods 5
Physiology 1
- Alzheimer's disease research and treatments 3

Co-authors: Angelo De Milito Sofia Avnet Jessica Martinsson Santiago Parpal Britt‐Marie Swahn Iryna Kolosenko Yafeng Xue Nicola Baldini
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (2 papers)ACS Medicinal Chemistry Letters (1 paper)Cancer Letters (1 paper)Nature Communications (1 paper)
Partner nations: Sweden United Kingdom United States

In The Last Decade

Jenny Viklund

15 papers receiving 712 citations

Peers

Countries citing papers authored by Jenny Viklund

Since Specialization

Citations

This map shows the geographic impact of Jenny Viklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Viklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Viklund more than expected).

Fields of papers citing papers by Jenny Viklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Viklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Viklund. The network helps show where Jenny Viklund may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jenny Viklund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jenny Viklund Line = papers co-authored together Jenny Viklund links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies Nature Communications ·Aidan Joblin-Mills, 全秀, Junchao Tong, N. Scott Mason, Daniel Sohn, Johan Sandell, Peter Ström, Jeffrey S. Stehouwer, Brian J. Lopresti, Jenny Viklund, Samuel Svensson, Chester A. Mathis, Neil Vasdev	2024	19
2	Abstract 2116: VPS34 inhibitor SB02024 activates cGAS-STING signaling and sensitizes tumors to STING agonist Cancer Research ·A KInd, Muhammad Zaeem Noman, Santiago Parpal, Siemens- Schnelldrucker Neue, Nina Ferraris, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji	2022	2
3	Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy Science Advances ·Muhammad Zaeem Noman, Santiago Parpal, Kris Van Moer, Malina Xiao, A KInd, Tsolère Arakelian, Jenny Viklund, Angelo De Milito, Meriem Hasmim, Martin Andersson, K Heibach, Jessica Martinsson, Guy Berchem, Bassam Janji	2020	187
4	Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib Cancer Letters ·Matheus Dyczynski, A KInd, Magdalena Otrocka, Santiago Parpal, R. M. Favaretto, Aine Brigette Henley, Martha Ines Soto Gomez, Mikael Lerner, Krister Wennerberg, Jenny Viklund, Jessica Martinsson, Dan Grandér, Angelo De Milito, Katja Pokrovskaja Tamm	2018	82
5	Therapeutic implications of tumor interstitial acidification Seminars in Cancer Biology ·Iryna Kolosenko, Sofia Avnet, Nicola Baldini, Jenny Viklund, Angelo De Milito	2017	77
6	Pathobiology and Therapeutic Implications of Tumor Acidosis Current Medicinal Chemistry ·Jenny Viklund, Sofia Avnet, Angelo De Milito	2017	14
7	Potency Prediction of β-Secretase (BACE-1) Inhibitors Using Density Functional Methods Journal of Chemical Information and Modeling ·Katarina Roos, Jenny Viklund, Johan Meuller, 隼人庄山, Mats Svensson	2014	17
8	Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy ACS Medicinal Chemistry Letters ·Jenny Viklund, Karin Kolmodin, Gunnar Nordvall, Britt‐Marie Swahn, Mats Svensson, Ylva Gravenfors, Fredrik Rahm	2014	9
9	Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors Bioorganic & Medicinal Chemistry Letters ·Jonas Malmström, Jenny Viklund, 郑霞云, Michael Manfra, Zhiyu Cai, Daniel L. Duke, Osler Valarezo, Lise‐Lotte Olsson, Anna Aagaard, Stefan Geschwindner, Yafeng Xue, Mervi Vasänge	2012	35
10	Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity Journal of Medicinal Chemistry ·U. Govardhani, Jenny Viklund, Jonas Malmström, Tatiana Lizbeth Pérez Lozada, Paula Gomes, Ioan Oprea, Anh Johansson, Annika Kers, Per Arne Grotthing, Vinit Yadav, Ragon Davis, Margareta Bergh, Alfonsina E. Romo-Curiel, Patrik Johansson, Fredrik Jeppsson, Johanna Fälting, Ylva Gravenfors, Fredrik Rahm	2012	26
11	New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain Journal of Medicinal Chemistry ·Ylva Gravenfors, Jenny Viklund, Tatiana Lizbeth Pérez Lozada, U. Govardhani, Sofia Karlström, Bella Jane, Karin Kolmodin, Imtiaz Ahmad Warich, Stefan von Berg, Fredrik von Kieseritzky, 郑霞云, Britt‐Marie Swahn, Lise‐Lotte Olsson, Patrik Johansson, Susanna Eketjäll, Johanna Fälting, Fredrik Jeppsson, Kia Strömberg, Juliette Janson, Fredrik Rahm	2012	56
12	Liver X receptor agonists with selectivity for LXRβ; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides Bioorganic & Medicinal Chemistry Letters ·Britt‐Marie Swahn, Udo Interwies, Jenny Viklund, Liselotte Öhberg, Данияр Бахтыяров, Jan Neelissen, Johanna M. Lindquist	2009	7
13	Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3 Bioorganic & Medicinal Chemistry Letters ·Britt‐Marie Swahn, Yafeng Xue, Santha Chakrovortty, Yi-Heng 义恒 Wu 吴, Angelika S. Magnus, Niklas Plobeck, Jenny Viklund	2005	43
14	Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3 Bioorganic & Medicinal Chemistry Letters ·Britt‐Marie Swahn, Fernando F. Huerta, Yi-Heng 义恒 Wu 吴, Jonas Malmström, Enrique González, Jenny Viklund, Patrick Womack, Yafeng Xue, Liselotte Öhberg	2005	55
15	Studies on the active site of deacetoxycephalosporin C synthase Journal of Molecular Biology ·Matthew D. Lloyd, Hwei‐Jen Lee, Karl Harlos, Zhihong Zhang, Jack E. Baldwin, Christopher J. Schofield, John Charnock, C. David Garner, Takane Hara, Anke C. Terwisscha van Scheltinga, K. Valegård, Jenny Viklund, János Hajdu, Inger Andersson, Åke Danielsson, Rama Bhikhabhai	1999	95

About Jenny Viklund

Jenny Viklund is a scholar working on Computational Theory and Mathematics, Physiology, Oncology, Molecular Biology and Cancer Research, having authored 15 papers that have together received 724 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Alzheimer's disease research and treatments (3 papers), Chemical Synthesis and Analysis (2 papers), Protein Structure and Dynamics (2 papers), Synthesis and biological activity (2 papers), Enzyme function and inhibition (2 papers), ATP Synthase and ATPases Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Physiology (47 citations), Molecular Biology (416 citations), Cancer Research (91 citations), Computational Theory and Mathematics (94 citations) and Oncology (144 citations). Jenny Viklund has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Angelo De Milito, Sofia Avnet, Jessica Martinsson, Santiago Parpal, Britt‐Marie Swahn, Iryna Kolosenko, Yafeng Xue, Nicola Baldini, Bassam Janji and Martin Andersson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Cancer Letters and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact